nominally significantp < 0.05
31 by including as IVs only the eGFR-associated genetic variants ( p < 5 × 10 −8 ) with additionally having directionally consistent and nominally significant p-value (p < 0.05) with i) eGFRcys or ii) BUN.
31 by including as IVs only the eGFR-associated genetic variants ( p < 5 × 10 −8 ) with additionally having directionally consistent and nominally significant p-value (p < 0.05) with i) eGFRcys or ii) BUN.
Furthermore, the glycine association in the GM2A gene showed a trend in the opposite direction in the FinnDiane study compared to the two general population studies.